Clinical Trial 44116

Bowling Green, KY 42101


Study H8H-MC-LAHV (Study LAHV) will enable a clinical assessment of lasmiditan in a pediatric patient population with migraine for which the medical need is substantial. This study is part of a pediatric clinical program that is intended to provide pivotal efficacy and safety data to support use of lasmiditan for acute treatment of migraine in pediatric patients.

Qualified Participants Must:

• 6-17 years old
• History of migraine attacks for more than 6 months lasting for at least 2 hours

Qualified Participants May Receive:

-No Cost Investigational Medication

-No Cost Study-Related Docotor Visits

-Compensation For Time and Travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.